Acute effects of long-acting bronchodilators on small airways detected in COPD patients by single-breath N2 test and lung P-V curve

Journal of Applied Physiology

Volumn 123, Issue 5, 2017, Pages 1266-1275

  Pecchiari, Matteo ^a   Santus, Pierachille ^b   Radovanovic, Dejan ^b   D'Angelo, Edgardo ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Bronchodilators; Chronic obstructive pulmonary disease; Closing volume; Lung pressure volume curve; Singlebreath nitrogen test

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRONCHODILATING AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT;

ADMINISTRATION AND DOSAGE; AGED; CHRONIC OBSTRUCTIVE LUNG DISEASE; DELAYED RELEASE FORMULATION; DRUG EFFECT; FEMALE; HUMAN; LUNG; LUNG FUNCTION TEST; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; TIDAL VOLUME; VITAL CAPACITY;

ADRENERGIC BETA-ANTAGONISTS; AGED; BRONCHODILATOR AGENTS; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; TIDAL VOLUME; VITAL CAPACITY;

EID: 85034056875     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00493.2017     Document Type: Article

References (40)

1. American Thoracic Society. Dyspnea. Mechanisms, assessment, and management: a consensus statement. Am J Respir Crit Care Med 159: 321-340, 1999. doi:10.1164/ajrccm.159.1.ats898.
2. Andersen LH, Haghfelt T. Regional lung function in asthmatics in remission, before and after fenoterol. Bull Eur Physiopathol Respir 16: 215-228, 1980.
3. Baydur A, Behrakis PK, Zin WA, Jaeger M, Milic-Emili J. A simple method for assessing the validity of the esophageal balloon technique. Am Rev Respir Dis 126: 788-791, 1982.
4. Bhatt SP, Soler X, Wang X, Murray S, Anzueto AR, Beaty TH, Boriek AM, Casaburi R, Criner GJ, Diaz AA, Dransfield MT, Curran- Everett D, Galbán CJ, Hoffman EA, Hogg JC, Kazerooni EA, Kim V, Kinney GL, Lagstein A, Lynch DA, Make BJ, Martinez FJ, Ramsdell JW, Reddy R, Ross BD, Rossiter HB, Steiner RM, Strand MJ, van Beek EJ, Wan ES, Washko GR, Wells JM, Wendt CH, Wise RA, Silverman EK, Crapo JD, Bowler RP, Han MK; COPDGene Investigators. Association between functional small airway disease and FEV1 decline in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 194: 178-184, 2016. doi:10.1164/rccm.201511-2219OC.
5. Borrill ZL, Houghton CM, Woodcock AA, Vestbo J, Singh D. Measuring bronchodilation in COPD clinical trials. Br J Clin Pharmacol 59: 379-384, 2005. doi:10.1111/j.1365-2125.2004.02261.x.
6. Brooks SM, Barber MO. Changes in closing volume measurement after isoproterenol inhalation. Am Rev Respir Dis 109: 198-204, 1974.
7. Buist AS, Ross BB. Predicted values for closing volumes using a modified single breath nitrogen test. Am Rev Respir Dis 107: 744-752, 1973a.
8. Buist AS, Ross BB. Quantitative analysis of the alveolar plateau in the diagnosis of early airway obstruction. Am Rev Respir Dis 108: 1078-1087, 1973b.
9. Cerveri I, Zoia MC, Fanfulla F, Spagnolatti L, Berrayah L, Grassi M, Tinelli C. Reference values of arterial oxygen tension in the middle-aged and elderly. Am J Respir Crit Care Med 152: 934-941, 1995. doi:10. 1164/ajrccm.152.3.7663806.
10. Collins JV, Clark TJ, Brown DJ. Airway function in healthy subjects and patients with left heart disease. Clin Sci Mol Med 49: 217-228, 1975.
11. Collins JV, Clark TJ, McHardy-Young S, Cochrane GM, Crawley J. Closing volume in healthy non-smokers. Br J Dis Chest 67: 19-27, 1973. doi:10.1016/0007-0971(73)90003-X.
12. Corda L, Gardenghi GG, Modina D, Montemurro LT, Novali M, Tantucci C. Effects on small airway obstruction of long-term treatments with beclomethasone/formoterol hydrofluoroalkane (metered-dose inhaler) versus fluticasone/salmeterol (dry-powder inhaler) in asthma: a preliminary study. Allergy Asthma Proc 32: 29-34, 2011. doi:10.2500/aap.2011.32.3477.
13. D'Angelo E, Pecchiari M, Baraggia P, Saetta M, Balestro E, Milic- Emili J. Low-volume ventilation causes peripheral airway injury and increased airway resistance in normal rabbits. J Appl Physiol (1985) 92: 949-956, 2002. doi:10.1152/japplphysiol.00776.2001.
14. D'Angelo E, Pecchiari M, Gentile G. Dependence of lung injury on surface tension during low-volume ventilation in normal open-chest rabbits. J Appl Physiol (1985) 102: 174-182, 2007. doi:10.1152/japplphysiol. 00405.2006.
15. D'Angelo E, Pecchiari M, Saetta M, Balestro E, Milic-Emili J. Dependence of lung injury on inflation rate during low-volume ventilation in normal open-chest rabbits. J Appl Physiol (1985) 97: 260-268, 2004. doi:10.1152/japplphysiol.01175.2003.
16. Demedts M, Clément J, Sta?nescu DC, van de Woestijne KP. Inflection point on transpulmonary pressure-volume curves and closing volume. J Appl Physiol 38: 228-235, 1975.
17. Demedts M, de Roo M, Cosemans J, Billiet L, van de Woestijne KP. Xenon and nitrogen single-breath washout curves in patients with airway obstruction. J Appl Physiol 41: 185-190, 1976.
18. Eltayara L, Becklake MR, Volta CA, Milic-Emili J. Relationship between chronic dyspnea and expiratory flow limitation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 154: 1726-1734, 1996. doi:10.1164/ajrccm.154.6.8970362.
19. Gennimata SA, Palamidas A, Karakontaki F, Kosmas EN, Koutsoukou A, Loukides S, Koulouris NG. Pathophysiology of evolution of small airways disease to overt COPD. COPD 7: 269-275, 2010. doi:10. 3109/15412555.2010.497515.
20. Georges R, Saumon G, Lafosse JE. [Closing volume and inhomogeneity of the ventilatory mechanical system (author's transl.)]. Bull Eur Physiopathol Respir 12: 371-385, 1976.
21. Global Initiative for Chronic Obstructive Pulmonary Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease [Online]. http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/[2017].
22. Hensley MJ, O'Cain CF, McFadden ER, Jr, Ingram RH Jr. Distribution of bronchodilatation in normal subjects: beta agonist versus atropine. J Appl Physiol Respir Environ Exerc Physiol 45: 778-782, 1978.
23. Hoffstein V, Duguid N, McClean P, Zamel N. Nitrogen and bolus closing volumes: the effect of beta-agonist bronchodilator aerosol. Bull Eur Physiopathol Respir 23: 5-8, 1987.
24. Hogg JC, McDonough JE, Suzuki M. Small airway obstruction in COPD: new insights based on micro-CT imaging and MRI imaging. Chest 143: 1436-1443, 2013. doi:10.1378/chest.12-1766.
25. Kitaoka H, Kawase I. A novel interpretation of closing volume based on single-breath nitrogen washout curve simulation. J Physiol Sci 57: 367-376, 2007. doi:10.2170/physiolsci.RP010807.
26. McCarthy D, Milic-Emili J. Closing volume in asymptomatic asthma. Am Rev Respir Dis 107: 559-570, 1973. doi:10.1164/arrd.1973.107.4.559.
27. McDonough JE, Yuan R, Suzuki M, Seyednejad N, Elliott WM, Sanchez PG, Wright AC, Gefter WB, Litzky L, Coxson HO, Paré PD, Sin DD, Pierce RA, Woods JC, McWilliams AM, Mayo JR, Lam SC, Cooper JD, Hogg JC. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 365: 1567-1575, 2011. doi:10.1056/NEJMoa1106955.
28. Mead J. The lung's "quiet zone". N Engl J Med 282: 1318-1319, 1970. doi:10.1056/NEJM197006042822311.
29. Milic-Emili J, Torchio R, D'Angelo E. Closing volume: a reappraisal (1967-2007). Eur J Appl Physiol 99: 567-583, 2007. doi:10.1007/s00421- 006-0389-0.
30. Olofsson J, Bake B, Blomqvist N, Skoogh BE. Effect of increasing bronchodilatation on the single breath nitrogen test. Bull Eur Physiopathol Respir 21: 31-36, 1985.
31. Pecchiari M, Pelucchi A, D'Angelo E, Foresi A, Milic-Emili J, D'Angelo E. Effect of heliox breathing on dynamic hyperinflation in COPD patients. Chest 125: 2075-2082, 2004. doi:10.1378/chest.125.6. 2075.
32. Pecchiari M, Radovanovic D, Santus P, D'Angelo E. Airway occlusion assessed by single breath N2 test and lung P-V curve in healthy subjects and COPD patients. Respir Physiol Neurobiol 234: 60-68, 2016. doi:10. 1016/j.resp.2016.09.006.
33. Popa VT, Werner P. Dose-related dilatation of airways after inhalation of metaproterenol sulfate. Chest 70: 205-211, 1976. doi:10.1378/chest.70.2.1.
34. Quanjer PH. Standardized lung function testing. Report working party. Bull Eur Physiopathol Respir 19, Suppl 5: 1-95, 1983.
35. Riley DJ, Liu RT, Edelman NH. Enhanced responses to aerosolized bronchodilator therapy in asthma using respiratory maneuvers. Chest 76: 501-507, 1979. doi:10.1378/chest.76.5.501.
36. Sackner MA, Silva G, Zucker C, Marks MB. Long-term effects of metaproterenol in asthmatic children. Am Rev Respir Dis 115: 945-953, 1977.
37. Santus P, Radovanovic D, Henchi S, Di Marco F, Centanni S, D'Angelo E, Pecchiari M. Assessment of acute bronchodilator effects from specific airway resistance changes in stable COPD patients. Respir Physiol Neurobiol 197: 36-45, 2014. doi:10.1016/j.resp.2014.1.012.
38. Scichilone N, Battaglia S, Sorino C, Paglino G, Martino L, Paternò A, Santagata R, Spatafora M, Nicolini G, Bellia V. Effects of extra-fine inhaled beclomethasone/formoterol on both large and small airways in asthma. Allergy 65: 897-902, 2010. doi:10.1111/j.1398- 9995.2009.02306.x.
39. Siegler D, Fukuchi Y, Engel L. Influence of bronchomotor tone on ventilation distribution and airway closure in asymptomatic asthma. Am Rev Respir Dis 114: 123-130, 1976.
40. Timmins SC, Diba C, Schoeffel RE, Salome CM, King GG, Tharmin C. Changes in oscillatory impedance and nitrogen washout with combination of fluticasone/salmeterol therapy in COPD. Respir Med 108: 344-350, 2014. doi:10.1016/j.rmed.2013.10.004.